Myriad Genetics Stock Technical Analysis
| MYGN Stock | USD 4.49 0.04 0.88% |
As of the 14th of February 2026, Myriad Genetics secures the Mean Deviation of 2.31, standard deviation of 3.07, and Risk Adjusted Performance of (0.13). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myriad Genetics, as well as the relationship between them.
Myriad Genetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Myriad, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MyriadMyriad Genetics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Myriad Genetics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 8.12 | Buy | 15 | Odds |
Most Myriad analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Myriad stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Myriad Genetics, talking to its executives and customers, or listening to Myriad conference calls.
Will Biotechnology sector continue expanding? Could Myriad diversify its offerings? Factors like these will boost the valuation of Myriad Genetics. Expected growth trajectory for Myriad significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Myriad Genetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.35) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Myriad Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Myriad Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Myriad Genetics' market price to deviate significantly from intrinsic value.
Understanding that Myriad Genetics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myriad Genetics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Myriad Genetics' market price signifies the transaction level at which participants voluntarily complete trades.
Myriad Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Myriad Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Myriad Genetics.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Myriad Genetics on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Myriad Genetics or generate 0.0% return on investment in Myriad Genetics over 90 days. Myriad Genetics is related to or competes with Castle Biosciences, Personalis, CareDx, Fulgent Genetics, DarioHealth Corp, AMN Healthcare, and Vir Biotechnology. Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in th... More
Myriad Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Myriad Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Myriad Genetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 14.61 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.67 |
Myriad Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Myriad Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Myriad Genetics' standard deviation. In reality, there are many statistical measures that can use Myriad Genetics historical prices to predict the future Myriad Genetics' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (0.40) |
Myriad Genetics February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.39) | |||
| Mean Deviation | 2.31 | |||
| Coefficient Of Variation | (603.18) | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.4 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (0.40) | |||
| Maximum Drawdown | 14.61 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.67 | |||
| Skewness | 0.513 | |||
| Kurtosis | 0.3591 |
Myriad Genetics Backtested Returns
Myriad Genetics has Sharpe Ratio of -0.2, which conveys that the firm had a -0.2 % return per unit of risk over the last 3 months. Myriad Genetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Myriad Genetics' Standard Deviation of 3.07, mean deviation of 2.31, and Risk Adjusted Performance of (0.13) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.28, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Myriad Genetics will likely underperform. At this point, Myriad Genetics has a negative expected return of -0.6%. Please make sure to verify Myriad Genetics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Myriad Genetics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Myriad Genetics has good predictability. Overlapping area represents the amount of predictability between Myriad Genetics time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Myriad Genetics price movement. The serial correlation of 0.76 indicates that around 76.0% of current Myriad Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.34 |
Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Myriad Genetics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Myriad Genetics across different markets.
About Myriad Genetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Myriad Genetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Myriad Genetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Myriad Genetics price pattern first instead of the macroeconomic environment surrounding Myriad Genetics. By analyzing Myriad Genetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Myriad Genetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Myriad Genetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.11 | 0.0665 | Price To Sales Ratio | 1.71 | 1.62 |
Myriad Genetics February 14, 2026 Technical Indicators
Most technical analysis of Myriad help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Myriad from various momentum indicators to cycle indicators. When you analyze Myriad charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.39) | |||
| Mean Deviation | 2.31 | |||
| Coefficient Of Variation | (603.18) | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.4 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (0.40) | |||
| Maximum Drawdown | 14.61 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.67 | |||
| Skewness | 0.513 | |||
| Kurtosis | 0.3591 |
Myriad Genetics February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Myriad stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 54,942 | ||
| Daily Balance Of Power | (0.16) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 4.59 | ||
| Day Typical Price | 4.55 | ||
| Price Action Indicator | (0.11) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Biotechnology sector continue expanding? Could Myriad diversify its offerings? Factors like these will boost the valuation of Myriad Genetics. Expected growth trajectory for Myriad significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Myriad Genetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.35) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Myriad Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Myriad Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Myriad Genetics' market price to deviate significantly from intrinsic value.
Understanding that Myriad Genetics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myriad Genetics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Myriad Genetics' market price signifies the transaction level at which participants voluntarily complete trades.